Physician profile
Eric Ryan Eidelman
NPI 1770046260
$2,636.06
in general payments reported to CMS, 2019-2025
28 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $628 · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,524.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $562.35 | 2024-2025 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $330.72 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $304.84 | 2024-2025 | Erleada |
| Teleflex LLC | $198.81 | 2025 | Barrigel, Urolift |
| Pfizer INC. | $149.74 | 2025 | |
| Endo USA, INC. | $119.60 | 2024-2025 | Aveed, Xiaflex |
| Progenics Pharmaceuticals, INC. | $111.98 | 2024-2025 | |
| Immunitybio, INC. | $89.14 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.09 | 2025 | |
| Antares Pharma, INC. | $65.01 | 2025 | Xyosted, Tlando |
| Novartis Pharmaceuticals Corporation | $63.93 | 2025 | |
| Astellas Pharma US INC | $61.14 | 2025 | Xtandi |
| Astrazeneca Pharmaceuticals Lp | $49.83 | 2025 | Lynparza |
| Accord Healthcare, INC. | $47.70 | 2025 | |
| Merck Sharp & Dohme LLC | $45.58 | 2024-2025 | Keytruda |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $44.25 | 2025 | Lofric |
| Verity Pharmaceuticals INC. | $38.30 | 2025 | Trelstar |
| Calyxo, INC. | $35.19 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $31.59 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $30.23 | 2024 | Opdivo |
| Tempus Ai, INC | $28.78 | 2025 | Xt Cdx |
| Blue Earth Diagnostics | $27.37 | 2025 | Posluma |
| Tolmar, INC. | $27.06 | 2025 | Eligard, Jatenzo |
| Olympus America INC. | $21.70 | 2025 | Itind System |
| Myriad Genetic Laboratories, INC. | $18.87 | 2024 | Prolaris |
| Bioprotect Medical, INC. | $18.67 | 2025 | Bioprotect Balloon Implant System |
| Sun Pharmaceutical Industries INC. | $17.62 | 2024 | |
| Abbvie INC. | $13.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Eidelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.